Annual Drug Patent Expirations for SYFOVRE
Syfovre is a drug marketed by Apellis Pharms and is included in one NDA. It is available from one supplier. There are ten patents protecting this drug.
This drug has one hundred and forty patent family members in twenty-four countries.
The generic ingredient in SYFOVRE is pegcetacoplan. One supplier is listed for this compound. Additional details are available on the pegcetacoplan profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
